301096 百诚医药
2024/06 - 中期
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
2020/12
人民币(K¥)
经营活动产生之现金流量净额(94,888)90,453259,413145,42454,360
投资活动产生之现金流量净额(382,683)(767,416)(690,871)(251,158)(255,787)
筹资活动产生之现金流量净额264,754244,482(366,476)1,982,131145,212
汇率变动对现金及现金等价物的影响-0(134)------
现金及现金等价物净增加/(减少)(212,817)(432,615)(797,934)1,876,397(56,214)
期初现金及现金等价物余额778,4531,211,0682,009,002132,605188,819
期末现金及现金等价物余额565,636778,4531,211,0682,009,002132,605